Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival

C. Rastellini, A. Salam, R. Kuddus, A. Aitouche, V. Subbotin, M. Braun, R. Leach, R. Peach, J. J. Fung, T. E. Starzl, A. S. Rao

Research output: Contribution to journalArticle

13 Scopus citations
Original languageEnglish (US)
Pages (from-to)1242-1243
Number of pages2
JournalTransplantation proceedings
Volume31
Issue number1-2
DOIs
StatePublished - Jan 1 1999

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Rastellini, C., Salam, A., Kuddus, R., Aitouche, A., Subbotin, V., Braun, M., Leach, R., Peach, R., Fung, J. J., Starzl, T. E., & Rao, A. S. (1999). Prevention of T-cell activation by rhCTLA4-Ig and anti-CD40L monoclonal antibody results in indefinite islet allograft survival. Transplantation proceedings, 31(1-2), 1242-1243. https://doi.org/10.1016/S0041-1345(98)01979-4